HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The blood coagulation status and the immunochemical and clinical indices in patients with active rheumatism during treatment with nerobol].

Abstract
Blood coagulation, immunobiochemical, and clinical characteristics were studied in patients with rheumatic fever running a protracted course treated by combined therapy including nerobol. To assess the therapeutic efficacy of nerobol, the patients were divided into 2 groups: Group 1 (30 patients) were administered combined antirheumatic therapy, Group 2 (30 patients) were administered the same + nerobol in a daily dose of 15 mg for 3-4 weeks. The findings evidence a positive effect of the drug on the status of patients in whom rheumatic fever runs a protracted course: blood procoagulative activity is reduced and anticoagulative activity elevated, blood immunobiochemical and clinical characteristics normalized.
AuthorsV A Likhatskaia, A V Epishin, P A Furtel'
JournalLaboratornoe delo (Lab Delo) Issue 8 Pg. 42-4 ( 1991) ISSN: 0023-6748 [Print] Russia (Federation)
Vernacular TitleSostoianie gemokoaguliatsii, immunobiokhimicheskie i klinicheskie pokazateli u bol'nykh aktivnym revmatizmom pri lechenii nerobolom.
PMID1724507 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Methandrostenolone
Topics
  • Adolescent
  • Adult
  • Blood Coagulation (drug effects)
  • Female
  • Humans
  • Male
  • Methandrostenolone (therapeutic use)
  • Middle Aged
  • Rheumatic Diseases (blood, drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: